☆ 4.5 Letter

Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients

BONE MARROW TRANSPLANTATION (2022)

Get Full Text
Add to Collection

Journal

BONE MARROW TRANSPLANTATION
Volume 57, Issue 2, Pages 309-311

Publisher

SPRINGERNATURE
DOI: 10.1038/s41409-021-01531-3

Keywords

-

Categories

Biophysics Oncology Hematology Immunology Transplantation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.